Tivantinib
98%
- Product Code: 124868
CAS:
905854-02-6
| Molecular Weight: | 369.42 g./mol | Molecular Formula: | C₂₃H₁₉N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 715.95℃ at 760 mmHg | |
| Density: | 1.5g/ml | Storage Condition: | -20℃ |
Product Description:
Tivantinib is primarily investigated for its potential as a targeted therapy in cancer treatment, specifically for cancers driven by the c-MET receptor tyrosine kinase. It has shown promise in clinical trials for hepatocellular carcinoma (HCC), where it targets and inhibits c-MET signaling, which is often overexpressed in this type of cancer. Additionally, tivantinib has been explored in non-small cell lung cancer (NSCLC) and other solid tumors with c-MET dysregulation. Its application focuses on improving outcomes in patients with advanced or metastatic disease, particularly those who have failed prior therapies. Research continues to evaluate its efficacy, safety, and potential combination with other anticancer agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $230.36 |
+
-
|
Tivantinib
Tivantinib is primarily investigated for its potential as a targeted therapy in cancer treatment, specifically for cancers driven by the c-MET receptor tyrosine kinase. It has shown promise in clinical trials for hepatocellular carcinoma (HCC), where it targets and inhibits c-MET signaling, which is often overexpressed in this type of cancer. Additionally, tivantinib has been explored in non-small cell lung cancer (NSCLC) and other solid tumors with c-MET dysregulation. Its application focuses on improving outcomes in patients with advanced or metastatic disease, particularly those who have failed prior therapies. Research continues to evaluate its efficacy, safety, and potential combination with other anticancer agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :